Literature DB >> 7911192

Azithromycin and typhoid.

M R Wallace, A A Yousif, N F Habib, D R Tribble.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7911192     DOI： 10.1016/s0140-6736(94)92604-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.

Authors:  N T Chinh; C M Parry; N T Ly; H D Ha; M X Thong; T S Diep; J Wain; N J White; J J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 2.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 3.  WITHDRAWN: Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever).

Authors:  Emmanuel E Effa; Hasifa Bukirwa
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

Review 4.  Current trends in typhoid Fever.

Authors:  Nancy F Crum
Journal:  Curr Gastroenterol Rep       Date:  2003-08

5.  Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model.

Authors:  Celina Jin; Malick M Gibani; Shaun H Pennington; Xinxue Liu; Alison Ardrey; Ghaith Aljayyoussi; Maria Moore; Brian Angus; Christopher M Parry; Giancarlo A Biagini; Nicholas A Feasey; Andrew J Pollard
Journal:  PLoS Negl Trop Dis       Date:  2019-12-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.